Literature DB >> 24165700

The relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease.

Soo Kyung Park1, Janet L Larson.   

Abstract

BACKGROUND: The prevalence of metabolic syndrome has been reported to be 20% to 50% in people with chronic obstructive pulmonary disease (COPD). Because such people are sedentary and physically inactive, they are at risk of metabolic syndrome. The extent of this problem, however, is not fully understood.
OBJECTIVES: This study examined the relationship of sedentary time and physical activity to metabolic syndrome and the components of metabolic syndrome in a population-based sample of people with COPD.
METHODS: This was a secondary analysis of existing cross-sectional data. Subjects with COPD (n = 223) were drawn from the National Health and Nutrition Examination Survey data set (2003-2006). Physical activity was measured by accelerometry. Waist circumference, triglyceride level, high-density lipoprotein cholesterol level, blood pressure, and fasting glucose level were used to describe metabolic syndrome. Descriptive and inferential statistics were used for analysis.
RESULTS: Fifty-five percent of the sample had metabolic syndrome. No significant differences in sedentary time and level of physical activity were found in people with COPD and metabolic syndrome and people with COPD only. However, those with a mean activity count of greater than 240 counts per minute had a lower prevalence of metabolic syndrome. Waist circumference and glucose level were significantly associated with the time spent in sedentary, light, and moderate to vigorous physical activity.
CONCLUSION: Metabolic syndrome is highly prevalent in people with COPD, and greater physical activity and less sedentary time are associated with lower rates of metabolic syndrome. This suggests that interventions to decrease the risk of metabolic syndrome in people with COPD should include both reducing sedentary time and increasing the time and intensity of physical activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24165700      PMCID: PMC4032377          DOI: 10.1097/JCN.0000000000000096

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  45 in total

1.  Leisure time but not occupational physical activity significantly affects cardiovascular risk factors in an adult population.

Authors:  F Sofi; A Capalbo; R Marcucci; A M Gori; S Fedi; C Macchi; A Casini; C Surrenti; R Abbate; G F Gensini
Journal:  Eur J Clin Invest       Date:  2007-11-01       Impact factor: 4.686

2.  Complex chronic comorbidities of COPD.

Authors:  L M Fabbri; F Luppi; B Beghé; K F Rabe
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

3.  Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab).

Authors:  Genevieve N Healy; Katrien Wijndaele; David W Dunstan; Jonathan E Shaw; Jo Salmon; Paul Z Zimmet; Neville Owen
Journal:  Diabetes Care       Date:  2007-11-13       Impact factor: 19.112

4.  The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study.

Authors:  Beate G Brouwer; Frank L J Visseren; Yolanda van der Graaf
Journal:  Am Heart J       Date:  2007-09-12       Impact factor: 4.749

5.  All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions.

Authors:  Louis Guize; Frédérique Thomas; Bruno Pannier; Kathy Bean; Bertrand Jego; Athanase Benetos
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

6.  The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women.

Authors:  M Halldin; M Rosell; U de Faire; M-L Hellénius
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-03-31       Impact factor: 4.222

7.  Year-long physical activity and metabolic syndrome in older Japanese adults: cross-sectional data from the Nakanojo Study.

Authors:  Sungjin Park; Hyuntae Park; Fumiharu Togo; Eiji Watanabe; Akitomo Yasunaga; Kazuhiro Yoshiuchi; Roy J Shephard; Yukitoshi Aoyagi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-10       Impact factor: 6.053

8.  The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.

Authors:  Henrik Watz; Benjamin Waschki; Anne Kirsten; Kai-Christian Müller; Gunther Kretschmar; Thorsten Meyer; Olaf Holz; Helgo Magnussen
Journal:  Chest       Date:  2009-06-19       Impact factor: 9.410

9.  Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus.

Authors:  Mats Arne; Christer Janson; Staffan Janson; Gunnar Boman; Ulla Lindqvist; Christian Berne; Margareta Emtner
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

10.  Physical activity and the metabolic syndrome in elderly German men and women: results from the population-based KORA survey.

Authors:  Valerie Hahn; Martin Halle; A Schmidt-Trucksäss; W Rathmann; C Meisinger; A Mielck
Journal:  Diabetes Care       Date:  2008-12-15       Impact factor: 19.112

View more
  17 in total

Review 1.  Health Benefits of Light-Intensity Physical Activity: A Systematic Review of Accelerometer Data of the National Health and Nutrition Examination Survey (NHANES).

Authors:  Eszter Füzéki; Tobias Engeroff; Winfried Banzer
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

Review 2.  Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance.

Authors:  Felipe Vilaça Cavallari Machado; Fabio Pitta; Nidia Aparecida Hernandes; Gisele Lopes Bertolini
Journal:  Endocrine       Date:  2018-03-06       Impact factor: 3.633

Review 3.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

4.  Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women.

Authors:  Suneela Zaigham; Hanan Tanash; Peter M Nilsson; Iram F Muhammad
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-17

5.  Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Janet L Larson
Journal:  West J Nurs Res       Date:  2013-11-29       Impact factor: 1.967

Review 6.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

7.  Does Lifestyle Exercise After a Cardiac Event Improve Metabolic Syndrome Profile in Older Adults?

Authors:  Kathy D Wright; Laura Moore-Schiltz; Abdus Sattar; Richard Josephson; Shirley M Moore
Journal:  J Cardiovasc Nurs       Date:  2018 May/Jun       Impact factor: 2.083

8.  Effect of Using a Wheeled Walker on Physical Activity and Sedentary Time in People with Chronic Obstructive Pulmonary Disease: A Randomised Cross-Over Trial.

Authors:  Kylie Hill; L W Cindy Ng; Nola Cecins; Vittoria R Formico; Vinicius Cavalheri; Sue C Jenkins
Journal:  Lung       Date:  2019-12-11       Impact factor: 2.584

Review 9.  Physical activity, sedentary behaviour and sleep in COPD guidelines: A systematic review.

Authors:  Hayley Lewthwaite; Tanja W Effing; Timothy Olds; Marie T Williams
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

10.  Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.

Authors:  Te-Wei Ho; Chun-Ta Huang; Sheng-Yuan Ruan; Yi-Ju Tsai; Feipei Lai; Chong-Jen Yu
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.